0001179110-12-009679.txt : 20120605 0001179110-12-009679.hdr.sgml : 20120605 20120605183353 ACCESSION NUMBER: 0001179110-12-009679 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120603 FILED AS OF DATE: 20120605 DATE AS OF CHANGE: 20120605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncothyreon Inc. CENTRAL INDEX KEY: 0001412067 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 260868560 STATE OF INCORPORATION: DE FISCAL YEAR END: 0612 BUSINESS ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 BUSINESS PHONE: (206) 801-2100 MAIL ADDRESS: STREET 1: 2601 FOURTH AVENUE STREET 2: SUITE 500 CITY: SEATTLE STATE: WA ZIP: 98121 FORMER COMPANY: FORMER CONFORMED NAME: Biomira CORP DATE OF NAME CHANGE: 20070911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENNEY CHRISTOPHER S CENTRAL INDEX KEY: 0001242880 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33882 FILM NUMBER: 12890381 MAIL ADDRESS: STREET 1: 10505 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgar.xml FORM 4 - X0305 4 2012-06-03 0 0001412067 Oncothyreon Inc. ONTY 0001242880 HENNEY CHRISTOPHER S 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 1 0 0 0 Common Stock 2012-06-03 4 F 0 2021 3.51 D 104267 D The shares were disposed of to the Issuer in a transaction approved by the board of directors in accordance with Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. The 2,021 shares represent 25% of the shares underlying the RSU grant to Dr. Henney that vested on June 3, 2012 and the transaction is designed to facilitate Dr. Henney's satisfaction of U.S. federal income tax obligations in connection with the vesting of such RSU grant. The Issuer's common stock was not traded on the vesting date. Accordingly, the price per share is equal to the closing price of the Issuer's common stock on June 1, 2012, the most recent date prior to the vesting date on which the Issuer's common stock was traded. Reflects 4,538 restricted share units previously owned and 99,729 shares directly beneficially owned by Dr. Henney. /s/ Barbara A. Mery, attorney-in-fact 2012-06-05